Arkolith/Insider Trading/MRNS/Form 4

Mayleben Timothy M

DirectorMARINUS PHARMACEUTICALS, INC. (MRNS) · full profile →Form 4 · filed Feb 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
16
5 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2025Disposed to issuer(D)2K$0.55$1K0
Feb 7, 2025Disposed to issuer(D)11K$0.55$6K0
Feb 7, 2025Disposed to issuer(D)2K$0.55$9130
Feb 7, 2025Disposed to issuer(D)5K$0.55$3K2K
Feb 7, 2025Disposed to issuer(D)2K$0.55$9130

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2025Disposed to issuer(D)9K—$00
Feb 11, 2025Disposed to issuer(D)25K—$00
Feb 11, 2025Disposed to issuer(D)17K—$00
Feb 11, 2025Disposed to issuer(D)12K—$00
Feb 11, 2025Disposed to issuer(D)16K—$00
Feb 11, 2025Disposed to issuer(D)21K—$00
Feb 11, 2025Disposed to issuer(D)10K—$00
Feb 11, 2025Disposed to issuer(D)2K—$00
Feb 11, 2025Disposed to issuer(D)2K—$00
Feb 11, 2025Disposed to issuer(D)3K—$00
Feb 11, 2025Disposed to issuer(D)9K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-011242) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML